Frontal assessment battery: A tool for screening minimal hepatic encephalopathy?

Figure 3 Median (interquartile range) total scores on the inhibitory control subtest (GO/NO-GO) for cirrhotic patients with overt hepatic encephalopathy (n = 16) vs cirrhotic patients without overt hepatic encephalopathy (n = 71) (Student’s t-test) and the control group (non-cirrhotic patients, n = 40) vs the case group (cirrhotic patients with and without overt hepatic encephalopathy, n = 87) (Mann-Whitney test).